Babalola, Stella
Kumoji, Kuor
Awantang, Grace N.
Oyenubi, Olamide A.
Toso, Michael
Tsang, Samantha
Bleu, Therese
Achu, Dorothy
Hedge, Judith
Schnabel, David C.
Cash, Shelby
Van Lith, Lynn M.
McCartney-Melstad, Anna C.
Nkomou, Yannick
Dosso, Abdul
Lahai, Wani
Hunter, Gabrielle C.
Funding for this research was provided by:
President's Malaria Initiative (AID-OAA-A-17-00017)
U.S. President's Malaria Initiative
Article History
Received: 20 May 2022
Accepted: 14 November 2022
First Online: 6 December 2022
Declarations
:
: The research protocols were reviewed and approved prior to the start of the study in each country. Ethical approval was obtained from the Johns Hopkins Bloomberg School of Public Health Institutional Review Board (Cote d’Ivoire: IRB08821; Cameroon: IRB09646; Sierra Leone: IRB09816), and from the National Ethics and Research Committee in Côte d’Ivoire, the Sierra Leone Ethics and Scientific Review Committee in Sierra Leone, and the National Human Health Research Ethics Committee in Cameroon. Voluntary written informed consent was obtained from each adult respondent, and parental consent with informed assent from each respondent less than 18 years of age. Interviewers read a written informed consent script to each respondent to obtain informed consent prior to interviewing them. Respondents’ confidentiality was protected in part because no personal identifiers were collected in the data collection tool and access to completed questionnaires was limited to only the research staff.
: The authors declare that they have no competing interests.
: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the U.S. Agency for International Development.